CP-25 exerts a protective effect against ConA-induced hepatitis via regulating inflammation and immune response

Nan Li(Xi'an Jiaotong University), Wu‐Yi Sun(Ministry of Education of the People's Republic of China)
Frontiers in Pharmacology
November 15, 2022
10.3389/fphar.2022.1041671
Cited by 4

Related Papers

Tangshen Formula Attenuates Diabetic Kidney Injury by Imparting Anti-pyroptotic Effects via the TXNIP-NLRP3-GSDMD Axis
|Frontiers in Pharmacology|2021|58
β-arrestin2 regulating β2-adrenergic receptor signaling in hepatic stellate cells contributes to hepatocellular carcinoma progression
|Journal of Cancer|2021|11
miR-221-3p Exacerbates Obesity-Induced Insulin Resistance by Targeting SOCS1 in Adipocytes
|Metabolites|2025|1